Vise Technologies, Inc.

Position in HLN — Haleon plc

CIK 1812090 NEW YORK, NY

Position in HLN

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$620,599

-$6,200 QoQ

Shares Held

61,998

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vise Technologies, Inc. holds $6,566,816 across 15 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	96,317	$1,783,790
2	ZTS	Zoetis Inc.	5,362	$633,842
3	TEVA	Teva Pharmaceutical Industries Ltd	21,030	$633,423
4	HLN	Haleon plc This page	61,998	$620,599
5	PBH	Prestige Consumer Healthcare Inc.	8,098	$479,968
6	UTHR	UNITED THERAPEUTICS Corp	790	$468,454
7	VTRS	Viatris Inc	30,669	$414,338
8	RDY	Dr Reddys Laboratories Ltd	23,603	$326,901

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$620,599	61,998	0.0%	Shares	Sole	2026-04-21
2025-12-31	$626,799	61,998	+8.2%	Shares	Sole	2026-02-11
2025-09-30	$513,756	57,275	-16.7%	Shares	Sole	2025-11-13
2025-06-30	$713,020	68,758	+16.3%	Shares	Sole	2025-08-07
2024-12-31	$564,052	59,125	+21.5%	Shares	Sole	2025-02-18
2024-09-30	$514,791	48,657	-5.0%	Shares	Sole	2024-11-13
2024-06-30	$423,151	51,229	+47.8%	Shares	Sole	2024-08-02
2024-03-31	$294,365	34,672	+1.6%	Shares	Sole	2024-05-15
2023-12-31	$280,824	34,122	+26.5%	Shares	Sole	2024-02-08
2023-09-30	$224,668	26,971	-14.7%	Shares	Sole	2023-10-31
2023-06-30	$264,833	31,603	+20.6%	Shares	Sole	2023-08-08
2023-03-31	$213,357	26,211	-9.5%	Shares	Sole	2023-05-10
2022-12-31	$231,608	28,951	+12.9%	Shares	Sole	2023-02-10
2022-09-30	$156,123	25,636	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.